pros and cons of glp-1 medications & weight loss drugs GLP-1 Medications: Is Ozempic the

Because retatrutide has not received MHRA marketing authorisation, there is currently no official MHRA guidance specifically addressing its dosing, safety profile, or use in clinical practice outside of approved trials

Adderall is FDA-approved to treat ADHD and narcolepsy

Starting BMI and total weight loss goal Patients starting at higher BMIs generally need longer treatment courses

Unlike traditional oral medications, injectable GLP-1 receptor agonists have significant advantages, including improved glycemic control, weight loss aid, and a lesser risk of hypoglycemia

No dedicated human coaching or patient community is currently available

doi: 10.7759/cureus.21536